Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Xavier Poiré"'
Autor:
Rafal Machowicz, Felipe Suarez, Wieslaw Wiktor-Jedrzejczak, Diderik-Jan Eikema, Liesbeth C. de Wreede, Henric-Jan Blok, Cecilia Isaksson, Hermann Einsele, Xavier Poiré, Suzanne van Dorp, Emmanouil Nikolousis, Jan-Erik Johansson, Guido Kobbe, Marco Zecca, Renate Arnold, Armin Gerbitz, Jürgen Finke, Jose Luis Díez-Martín, Francesca Bonifazi, Grant McQuaker, Stig Lenhoff, Pierre-Simon Rohrlich, Matthias Theobald, Per Ljungman, Matthew Collin, Michael H. Albert, Gerhard Ehninger, Kristina Carlson, Kazimierz Halaburda, Kai Lehmberg, Stefan Schönland, Ibrahim Yakoub-Agha, Andrew R. Gennery, Arjan C. Lankester, Nicolaus Kröger
Publikováno v:
Bone Marrow Transplantation, 57, 817-823
Bone Marrow Transplantation, 57, 5, pp. 817-823
Bone marrow transplantation, Vol. 57, no.5, p. 817-823 (2022)
Bone Marrow Transplantation, 57(5), 817-823. SPRINGERNATURE
Bone Marrow Transplantation, 57, 5, pp. 817-823
Bone marrow transplantation, Vol. 57, no.5, p. 817-823 (2022)
Bone Marrow Transplantation, 57(5), 817-823. SPRINGERNATURE
Contains fulltext : 251601.pdf (Publisher’s version ) (Closed access) Hemophagocytic lymphohistiocytosis (HLH; hemophagocytic syndrome) is a rare syndrome of potentially fatal, uncontrolled hyperinflammation. Allogeneic hematopoietic stem cell tran
Autor:
Rama Al Hamed, Myriam Labopin, Etienne Daguindau, Riitta Niittyvuopio, Anne Huynh, Gerard Socié, Micha Srour, Jean Henri Bourhis, Nicolaus Kröger, Eleni Tholouli, Goda Choi, Xavier Poiré, Hans Martin, Marie‐Thérèse Rubio, Pavel Jindra, Didier Blaise, Dietrich Beelen, Hélène Labussière‐Wallet, Arnon Nagler, Ali Bazarbachi, Mohamad Mohty
Publikováno v:
Cancer Medicine, Vol 11, Iss 4, Pp 1068-1080 (2022)
Cancer Medicine
Cancer Medicine, 2022, 11 (4), pp.1068-1080. ⟨10.1002/cam4.4218⟩
Cancer Medicine, 2022, ⟨10.1002/cam4.4218⟩
Cancer medicine, 11(4), 1068-1080. Wiley
Cancer Medicine
Cancer Medicine, 2022, 11 (4), pp.1068-1080. ⟨10.1002/cam4.4218⟩
Cancer Medicine, 2022, ⟨10.1002/cam4.4218⟩
Cancer medicine, 11(4), 1068-1080. Wiley
Nucleophosmin-1 (NPM1) mutations in acute myeloid leukemia (AML) confer a survival advantage in the absence of FLT3-internal tandem duplication (FLT3-ITD). Here, we investigated the main predictors of outcome after allogeneic hematopoietic stem cell
Autor:
Baptiste Le Calvez, Benoit Tessoullin, Loïc Renaud, Carmen Botella-Garcia, Micha Srour, Steven Le Gouill, Gaelle Guillerm, Rémy Gressin, Stéphanie Nguyen Quoc, Sabine Furst, Adrien Chauchet, David Sibon, Philippe Lewalle, Xavier Poiré, Natacha Maillard, Alban Villate, Michael Loschi, Jérôme Paillassa, Yves Beguin, Rémy Dulery, Jean-Jacques Tudesq, Amandine Fayard, Marie C. Béné, Vincent Camus, Patrice Chevallier, Amandine Le Bourgeois
Publikováno v:
Acta Oncologica
Acta Oncologica, 2022, 61 (11), pp.1332-1338. ⟨10.1080/0284186X.2022.2130709⟩
Acta Oncologica, 2022, 61 (11), pp.1332-1338. ⟨10.1080/0284186X.2022.2130709⟩
Background: Despite therapeutic progress, 10 to 30% of adult patients with primary mediastinal B cell lymphoma (PMBCL) are primary refractory or experience early relapse (R/R). Allogeneic stem cell transplantation (allo-HSCT) thus remains a potential
Autor:
Francesca A M Kinsella, Didier Blaise, Péter Reményi, John A. Snowden, Jürgen Kuball, Marie-Thérèse Rubio, Patrice Chevallier, Etienne Daguindau, Nicolaus Kröger, Jörg Cammenga, Donal McLornan, Johan Maertens, Jean-Baptiste Mear, Damian Finnegan, Patrick Hayden, Xavier Poiré, Juan Carlos Hernández-Boluda, Vittoria Malpassuti, Tomasz Czerw, Ibrahim Yakoub-Agha, Sébastien Maury, Linda Koster, Simona Iacobelli, Emma Watz, Marie Robin
Publikováno v:
Bone marrow transplantation, Vol. 57, no.2, p. 261-270 (2022)
BONE MARROW TRANSPLANTATION
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
BONE MARROW TRANSPLANTATION
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Introduction: Cellular composition of grafts is believed to be one of the significant determinants of outcomes of reduced-intensity conditioning (RIC) allogenic hematopoietic cell transplantation (allo-HCT). However, inconsistent results of the influ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b716cad90a557c3939ea2ea72cecdc
https://hdl.handle.net/2078.1/261776
https://hdl.handle.net/2078.1/261776
Autor:
Marc E. Uknis, Jingyang Wu, Catherine Cordonnier, Xavier Poiré, Peter Jaksch, Faouzi Saliba, Oliver Witzke, Johan Maertens, Anna Wijatyk, Stephen Villano
Publikováno v:
New England Journal of Medicine. 381:1136-1147
Maribavir is a benzimidazole riboside with activity against cytomegalovirus (CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in transplant recipients is not known.In a phase 2, open-label, maribavir dose-blinded t
Autor:
Harry C. Schouten, Myriam Labopin, Jordi Esteve, Arnon Nagler, Xavier Poiré, Didier Blaise, Johan Maertens, Patrice Chevallier, Tsila Zuckerman, Norbert Ifrah, Gabriela M. Baerlocher, Emmanuelle Polge, Mohamad Mohty, Eric Deconinck, Edouard Forcade, Liisa Volin, Alessandro Rambaldi
Publikováno v:
American journal of hematology, Vol. 94, no. 2, p. 231-239 (2019)
American Journal of Hematology, 94(2), 231-239. Wiley
American journal of hematology
American journal of hematology, 2018, 94 (2), pp.231-239. ⟨10.1002/ajh.25355⟩
American Journal of Hematology, 94(2), 231-239. Wiley
American journal of hematology
American journal of hematology, 2018, 94 (2), pp.231-239. ⟨10.1002/ajh.25355⟩
International audience; Acute myeloid leukemia (AML) in first remission (CR1) with isolated NPM1 mutation (iNPM1m) is considered a good prognosis genotype, although up to one-third relapse. To evaluate the best transplant strategy, we retrospectively
Autor:
Stephanie Nguyen-Quoc, Hélène Salvator, Catherine Paillard, Michael Loschi, Jacques-Olivier Bay, Marie Robin, Yves Beguin, Marie-Thérèse Rubio, Ana Berceanu, Marie-Laure Chabi, Constance Xhaard, Aliénor Xhaard, Patrice Ceballos, Bénédicte Bruno, Maud D'Aveni, Jean-Hugues Dalle, Xavier Poiré, Tereza Coman, Karin Bilger, Yves Chalandon
Publikováno v:
British journal of haematology, Vol. 192, No 5 (2021) pp. e121-e124
British Journal of Haematology
British Journal of Haematology, Wiley, 2021, 192 (5), pp.e121-e124. ⟨10.1111/bjh.17260⟩
British journal of haematology, Vol. 192, no.5, p. e121-e124 (2021)
British Journal of Haematology
British Journal of Haematology, Wiley, 2021, 192 (5), pp.e121-e124. ⟨10.1111/bjh.17260⟩
British journal of haematology, Vol. 192, no.5, p. e121-e124 (2021)
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68d2aa0eab6239124abb4dcda267e613
https://archive-ouverte.unige.ch/unige:158639
https://archive-ouverte.unige.ch/unige:158639
Autor:
Arnold Ganser, Jan J. Cornelissen, Xavier Poiré, Ibrahim Yakoub-Agha, Mauricette Michallet, Liisa Volin, Didier Blaise, Edouard Forcade, Jürgen Finke, Jordi Esteve, Mohamad Mohty, Arnon Nagler, Myriam Labopin, Carlos Richard Espiga, Johan Maertens, Emmanuelle Polge
Publikováno v:
Haematologica, 105(2), 414-423. Ferrata Storti Foundation
Haematologica
Haematologica
Deletion 5q or monosomy 5 (-5/5q-) in acute myeloid leukemia (AML) is a common high-risk feature that is referred to allogeneic stem cell transplantation. However, -5/5q- is frequently associated with other high-risk cytogenetic aberrations such as c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4166a9643fd3709a85aac3ae0f07b1b0
http://hdl.handle.net/10138/313286
http://hdl.handle.net/10138/313286
Autor:
Andrea Janíková, Eva González-Barca, Achilles Anagnostopoulos, Peter Dreger, Maija Itälä-Remes, Elizabeth Vandenberghe, John A. Snowden, J. Y. Cahn, Esa Jantunen, Martina Crysandt, Wilfried Schroyens, Giuseppe Gritti, S. González de Villambrosia, Herve Finel, Xavier Leleu, Xavier Poiré, Ariane Boumendil, Albert Esquirol, Mark Bishton, Joerg Thomas Bittenbring, Silvia Montoto, Didier Blaise, Benedetto Bruno, Tamás Masszi, Marek Trněný, Mariagrazia Michieli, Z. N. Özkurt, Anna Sureda, J Maertens
Publikováno v:
Bone marrow transplantation
BONE MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BONE MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Autologous hematopoietic stem cell transplantation (auto-HSCT) is the standard of care for patients with diffuse large B-cell lymphoma (DLBCL) who relapse/progress after first line chemoimmunotherapy. Long-term outcome of those who relapse after tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b9adb1a4a22135571bf6512e4cf714e
http://hdl.handle.net/2318/1732799
http://hdl.handle.net/2318/1732799
Autor:
Ibrahim Yakoub-Agha, Xavier Poiré, Marek Trneny, Wilfried Schroyens, Linda Koster, Juan Bargay Lleonart, Denis Caillot, Péter Reményi, Nicolaas Schaap, Loic Fouillard, Anastasia Pouli, Maija Itälä-Remes, Dominique Bron, Nico Gagelmann, Vincenzo Pavone, Didier Blaise, Jean-Yves Cahn, Johan Maertens, Nicolaus Kröger, Rocio Parody Porras, Pietro Pioltelli, Roland Fenk, Jakob Passweg, Diderik Jan Eikema, Maurizio Musso, Stefan Schönland, Laurent Garderet
Publikováno v:
Biology of blood and marrow transplantation
Biology of Blood and Marrow Transplantation, 25, 11, pp. 2134-2142
Biology of Blood and Marrow Transplantation, 25, 2134-2142
Biology of blood and marrow transplantation, Vol. 25, no.11, p. 2134-2142 (2019)
Biology of Blood and Marrow Transplantation, 25, 11, pp. 2134-2142
Biology of Blood and Marrow Transplantation, 25, 2134-2142
Biology of blood and marrow transplantation, Vol. 25, no.11, p. 2134-2142 (2019)
Although high-dose therapy and autologous stem cell transplant combined with novel agents continues to be the hallmark of first-line treatment in newly diagnosed transplant-eligible multiple myeloma patients, the impact of tandem autologous or autolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c756da7aef0ec31fe79a73fa5e8e3b2c
https://lirias.kuleuven.be/handle/123456789/639716
https://lirias.kuleuven.be/handle/123456789/639716